Lack of association between HLA class II alleles and in Vitro replication capacities of recombinant viruses encoding HIV-1 Subtype C gag-protease from chronically infected individuals

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 1273-1276

  Wright, Jaclyn K ^a   Brumme, Zabrina L ^b,c   Julg, Boris ^a,d   van der Stok, Mary ^a   Mncube, Zenele ^a   Gao, Xiaojiang ^e   Carlson, Jonathan M ^f   Goulder, Philip J R ^a,d,g   Walker, Bruce D ^a,d,h   Brockman, Mark A ^b,c   Ndung'u, Thumbi ^a,d  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b SIMON FRASER UNIVERSITY   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e SAIC FREDERICK INC   (United States)

^f MICROSOFT RESEARCH   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HLA ANTIGEN CLASS 2; PROTEINASE;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS ATTENUATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TYPING;

ALLELES; CD4-POSITIVE T-LYMPHOCYTES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HIV-1; HUMANS; PEPTIDE HYDROLASES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856876953     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06533-11     Document Type: Article

References (31)

1. Banke S, Lillemark MR, Gerstoft J, Obel N, Jørgensen, LB. 2009. Positive selection pressure introduces secondary mutations at Gag cleavage sites in human immunodeficiency virus type 1 harboring major protease resistance mutations. J. Virol. 83:8916-8924.
2. Blankson J. 2010. Control of HIV-1 replication in elite suppressors. Discov. Med. 9:261-266.
3. Brockman M, et al. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J. Virol. 84:11937-11949.
4. Brockman MA, et al. 2007. Escape and compensation from early HLAB57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 81:12608-12618.
5. Brockman MA, Tanzi GO, Walker BD, Allen TM. 2006. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. J. Virol. Methods 131:134-142.
6. Carlson JM, et al. 2008. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput. Biol. 4:1-23.
7. Carrington M, O'Brien SJ. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
8. Chen Y, et al. 1997. Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-Term Survivor Study. Hum. Immunol. 55:154-162.
9. Chevalier M, et al. 2009. Abstr. AIDS Vaccine 2009 Conference, abstr P16-31.
10. Chopera DR, et al. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4:1-12.
11. Crawford H, et al. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 206:909-919.
12. Douek DC, et al. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98.
13. Harcourt GC, Garrard S, Davenport MP, Edwards A, Phillips RE. 1998. HIV-1 variation diminishes CD4 T lymphocyte recognition. J. Exp. Med. 188:1785-1793.
14. + T-cell responses without highfrequency fixation of mutations. J. Virol. 83:8722-8732.
15. Julg B, et al. 2011. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 cladeCand B infection. J. Infect. Dis. 203:803-809.
16. Kaslow RA, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
17. Koeppe JR, Campbell TB, Rapaport EL, Wilson CC. 2006. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia. J. Acquir. Immune Defic. Syndr. 41:140-148.
18. Malhotra U, et al. 2001. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J. Clin. Invest. 107:505-517.
19. Marsh SG, et al. 2010. An update to HLA nomenclature, 2010. Bone Marrow Transplant. 45:846-848.
20. Martin MP, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740.
21. Martinez-Picado J, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
22. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10:11-23.
23. Miura T, et al. 2009. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J. Virol. 83:140-149.
24. Miura T, et al. 2010. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J. Virol. 84:7581-7591.
25. Mothe B, Ibarrondo J, Llano A, Brander C. 2009. Virological, immune and host genetics markers in the control of HIV infection. Dis. Markers 27:105-120.
26. Rychert J, Saindon S, Placek S, Daskalakis D, Rosenberg ES. 2007. Sequence variation occurs in CD4 epitopes during early HIV infection. J. Acquir. Immune Defic. Syndr. 46:261-267.
27. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U. S. A. 100:9440-9445.
28. Streeck H, Nixon DF. 2010. T cell immunity in acute HIV-1 infection. J. Infect. Dis. 202(Suppl 2):S302-S308.
29. Sun JC, Williams MA, Bevan MJ. 2004. CD4+T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat. Immunol. 5:927-933.
30. van Opijnen T, Berkhout B. 2005. The host environment drives HIV-1 fitness. Rev. Med. Virol. 15:219-233.
31. Wright JK, et al. 2010. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J. Virol. 84:10820-10831.